NASDAQ$SIGA

SIGA Technologies, Inc · Q2 2024 earnings

Q2 2024 earnings · · Investor relations

Briefing

SIGA Technologies' Q2 2024 financial performance was marked by revenue generation and strategic advancement.

SIGA Technologies reported a strong second quarter in 2024, with total revenues of $21.8 million, driven by product sales of $20.7 million. The company achieved a net income of $1.8 million, resulting in a diluted income per share of $0.03. Additionally, SIGA received a $113 million procurement order from the U.S. Government for oral TPOXX in July.

  • Generated $21 million in total revenues, with $20.7 million from product sales.
  • Achieved net income of $1.8 million, resulting in diluted earnings per share of $0.03.
  • Received a $113 million procurement order from the U.S. Government for oral TPOXX in July.
  • Delivered $18 million of IV TPOXX to the U.S. SNS and $3 million of oral TPOXX to a new customer in the ASEAN region during Q2 2024.

Headline financials

Total Revenue

$21.8M

Previous: $5.88M+271.0%
EPS

$0.03

Previous: -$0.04+175.0%
Capital Expenditures

-$2.19K

Previous: -$21.7K+89.9%
Free Cash Flow

$1.83M

Previous: -$2.9M+163.2%
Net Income

$1.83M

Previous: -$2.88M+163.7%
Operating Income

$1.08M

Previous: -$4.64M+123.3%
Gross Profit

$9.5M

Previous: $4.9M+93.7%
R&D Expense

$2.89M

No prior period
Stock-Based Comp

$932K

Previous: $721K+29.2%

Revenue & EPS history

SIGA Technologies · Revenue · Quarterly

$21.8M

Q2 2024+271%vs Q2 2023
Beat estimate in 0 of 3 quarters(0%)
ActualEstimate

Revenue by segment

SIGA Technologies · $9.24M total across 2 segments · Q3 2023

  • Product Sales
    $7.96M-87.9%
  • R&D Revenues
    $1.28M-80.6%

Forward guidance

SIGA Technologies is focused on diversifying and expanding its revenue base, progressing its clinical programs, negotiating the next contract with the U.S. Government, and promoting public health.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2024

Historical avgQ2 2024

-0.2%

Avg return

Earnings day

+0.5%

Avg return

5 days after

+2.4%

Avg return

30 days after

41%

26 / 64 earnings

Positive

+31.9%

Q4 2023

Best reaction

-27.8%

Q1 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.4%-5.5%-8.5%
Q4 2025-3.0%-3.4%-22.8%
Q3 2025-20.2%-24.0%-24.1%
Q1 2025+4.4%+9.0%+10.8%
Q4 2024+7.0%+0.5%+6.4%
Q3 2024-1.9%-8.5%-9.8%
Q2 2024-12.8%-14.3%-9.5%
Q1 2024-27.8%-28.2%-26.7%
Q4 2023+31.9%+49.9%+88.3%
Q3 2023-4.4%-2.2%+16.9%
Q2 2023-3.7%-10.0%-21.9%
Q1 2023+5.1%+1.8%-0.7%
Q4 2022-3.8%-7.8%-13.4%
Q3 2022+7.5%+9.8%+1.1%
Q2 2022+27.4%+24.6%-21.0%
Q1 2022+3.6%+4.0%+60.7%
Q4 2021+3.0%+6.6%+22.4%
Q3 2021-0.7%+0.0%+2.8%
Q2 2021-2.9%-4.0%+9.1%
Q1 2021-0.7%-8.4%-10.4%
Q4 2020+1.7%+9.3%+1.2%
Q3 2020+2.0%+3.4%-0.9%
Q2 2020+14.3%+5.5%-1.9%
Q1 2020-1.4%+1.4%+2.9%
Q4 2019+10.4%+0.4%+0.2%
Q3 2019-3.2%-1.8%-19.8%
Q2 2019+0.2%-1.7%+2.7%
Q1 2019+1.5%-1.3%-12.8%
Q4 2018-4.4%-1.6%-6.3%
Q3 2018+8.4%+5.7%+29.1%
Q2 2018+0.3%+7.7%+1.4%
Q1 2018-0.5%+2.4%-3.9%
Q4 2017-0.6%-7.0%-2.3%
Q3 2017+2.8%-1.1%+3.9%
Q2 2017-1.6%-1.6%-1.9%
Q1 2017-0.3%+0.6%-8.0%
Q4 2016-0.6%+0.0%-4.1%
Q3 2016-5.7%+3.8%+54.8%
Q2 2016+4.5%+4.1%+11.4%
Q1 2016+1.1%
Q4 2015+1.1%
Q3 2015+2.4%
Q2 2015-0.9%
Q1 2015+5.7%
Q4 2014-1.3%
Q3 2014-0.7%
Q2 2014-4.9%
Q1 2014-1.4%
Q4 2013-2.7%
Q3 2013-3.5%
Q2 2013-2.8%
Q1 2011-2.4%
Q4 2012-2.5%
Q3 2012+6.5%
Q2 2012+5.3%
Q1 2012+4.5%
Q4 2011-1.4%
Q4 2009-1.4%
Q3 2010-6.1%
Q3 2011-6.1%
Q2 2011-12.0%
Q2 2010-12.0%
Q4 2010-12.0%
Q1 2010-1.4%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro